Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Waree Rinsurongkawong

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2010
Building networks with microarray dataBradley M Broom, Waree Rinsurongkawong, Lajos Pusztai, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 27, 2010
Mortality in the randomized, controlled lung intergroup trial of isotretinoinJ Jack Lee, Lei Feng, Daniel S Reshef, et al.
JTO Clinical and Research Reports|November 25, 2021
Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With <i>EGFR</i> or <i>ALK</i> AlterationsWhitney E Lewis, Lingzhi Hong, Frank E Mott, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2020
Concurrent use of aspirin with osimertinib is associated with improved survival in advanced EGFR-mutant non-small cell lung cancerXiaoke Liu, Lingzhi Hong, Monique Nilsson, et al.
BMJ Open|November 25, 2025
Stiefel MD Anderson OroPharynx cancer (MDA-OPC) cohort: a single-institution, prospective longitudinal outcomes studyAmy Moreno, Ariana J Sahli, Faye Johnson, et al.
Clinical Lung Cancer|February 26, 2022
Clinical Effectiveness and Safety of Anti-PD-(L)1 Therapy Among Older Adults With Advanced Non-Small Cell Lung CancerMehmet Altan, Eric K Singhi, Michelle Worst, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
LLM-Driven Extraction of NI-RADS and Imaging Tumor Characteristics to Enhance Oropharyngeal Cancer Survivorship SurveillanceWenye Song, Lina Shbita, Isabelle Jia Hui Jang, et al.
BMC Cancer|February 2, 2020
Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutationsRoberto Ruiz-Cordero, Junsheng Ma, Abha Khanna, et al.
Clinical Lung Cancer|October 4, 2018
Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable AlterationsVincent K Lam, Hai T Tran, Kimberly C Banks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
<i>STK11</i>/LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase InhibitionPiyada Sitthideatphaiboon, Ana Galan-Cobo, Marcelo V Negrao, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2010
Building networks with microarray dataBradley M Broom, Waree Rinsurongkawong, Lajos Pusztai, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 27, 2010
Mortality in the randomized, controlled lung intergroup trial of isotretinoinJ Jack Lee, Lei Feng, Daniel S Reshef, et al.
JTO Clinical and Research Reports|November 25, 2021
Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With <i>EGFR</i> or <i>ALK</i> AlterationsWhitney E Lewis, Lingzhi Hong, Frank E Mott, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2020
Concurrent use of aspirin with osimertinib is associated with improved survival in advanced EGFR-mutant non-small cell lung cancerXiaoke Liu, Lingzhi Hong, Monique Nilsson, et al.
BMJ Open|November 25, 2025
Stiefel MD Anderson OroPharynx cancer (MDA-OPC) cohort: a single-institution, prospective longitudinal outcomes studyAmy Moreno, Ariana J Sahli, Faye Johnson, et al.
Clinical Lung Cancer|February 26, 2022
Clinical Effectiveness and Safety of Anti-PD-(L)1 Therapy Among Older Adults With Advanced Non-Small Cell Lung CancerMehmet Altan, Eric K Singhi, Michelle Worst, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
LLM-Driven Extraction of NI-RADS and Imaging Tumor Characteristics to Enhance Oropharyngeal Cancer Survivorship SurveillanceWenye Song, Lina Shbita, Isabelle Jia Hui Jang, et al.
BMC Cancer|February 2, 2020
Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutationsRoberto Ruiz-Cordero, Junsheng Ma, Abha Khanna, et al.
Clinical Lung Cancer|October 4, 2018
Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable AlterationsVincent K Lam, Hai T Tran, Kimberly C Banks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
<i>STK11</i>/LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase InhibitionPiyada Sitthideatphaiboon, Ana Galan-Cobo, Marcelo V Negrao, et al.
Pageof 4